Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Consolidated Net Income: 2020-2024

Historic Consolidated Net Income for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to -$89.6 million.

  • Terns Pharmaceuticals' Consolidated Net Income fell 31.27% to -$21.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$90.3 million, marking a year-over-year decrease of 49.01%. This contributed to the annual value of -$89.6 million for FY2024, which is 0.79% up from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Consolidated Net Income of -$89.6 million as of FY2024, which was up 0.79% from -$90.3 million recorded in FY2023.
  • Over the past 5 years, Terns Pharmaceuticals' Consolidated Net Income peaked at -$41.8 million during FY2020, and registered a low of -$90.3 million during FY2023.
  • Over the past 3 years, Terns Pharmaceuticals' median Consolidated Net Income value was -$89.6 million (recorded in 2024), while the average stood at -$80.1 million.
  • In the last 5 years, Terns Pharmaceuticals' Consolidated Net Income tumbled by 49.01% in 2023 and then increased by 0.79% in 2024.
  • Over the past 5 years, Terns Pharmaceuticals' Consolidated Net Income (Yearly) stood at -$41.8 million in 2020, then decreased by 20.33% to -$50.2 million in 2021, then fell by 20.59% to -$60.6 million in 2022, then plummeted by 49.01% to -$90.3 million in 2023, then climbed by 0.79% to -$89.6 million in 2024.